CTOs on the Move

Sanhua International

www.sanhuausa.com

 
Sanhua International was established in 2002 by a group of highly experienced professionals in the HVAC industry. Since its inception, Sanhua International has grown quickly. Today, it is a multi-faceted company that deals with not only the HVAC business but also hi-tech equipment and biotech products/services. Microsoft Media Player 9 required.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.sanhuausa.com
  • 8400 Industrial Parkway
    Plain City, OH USA 43064
  • Phone: 614.873.7400

Executives

Name Title Contact Details

Similar Companies

Critical Data Marketing Inc

Critical Data Marketing Inc is a Spokane, WA-based company in the Business Services sector.

Dada Tours and Travel

Dada Tours and Travel is a Los Angeles, CA-based company in the Business Services sector.

Hard Rock Stadium

Hard Rock Stadium is a multipurpose football stadium located in Miami Gardens, Florida, a city north of Miami.

Qarbon

Qarbon is a San Jose, CA-based company in the Business Services sector.

Satellos

Satellos is a regenerative medicine company dedicated to developing novel therapeutics that stimulate or restore muscle regeneration in severe disorders. Satellos was founded on the discovery that dysregulated muscle stem-cell polarity - a process that balances replenishment of muscle stem cells and production of specialized tissue cells- can lead to the inability of the body to properly repair and regenerate muscle throughout life. Satellos` lead program is focused on developing an oral therapeutic drug for Duchenne muscular dystrophy that serves to correct this dysregulation which Satellos has identified as a root cause of the progressive nature of this disease. Satellos believes defects in muscle regeneration play a critical underlying role in numerous muscle disorders spanning rare diseases through to mass market indications. Accordingly, Satellos applies its proprietary discovery platform, MyoReGenX, to identify regulatory pathways and drug candidates to treat muscle disorders where stem cell polarity is dysregulated.